MS Meds in Breastfeeding Mothers Safe for Infants
Breastfeeding by women with MS or NMSOD who are taking anti-CD20 IgG1 monoclonal antibodies appears to be safe for infants, new research suggests.
Source: medscape.com
Stay updated with breaking news from First Trimester Screening Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Breastfeeding by women with MS or NMSOD who are taking anti-CD20 IgG1 monoclonal antibodies appears to be safe for infants, new research suggests.
Two studies report few complications from continuing ocrelizumab and natalizumab into pregnancy, with high live birth rates, a decline in elective abortions, and few major congenital abnormalities in newborns.